Nora Therapeutics, Inc. — Form D
Nora Therapeutics, Inc. of PALO ALTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2014-04-23. The offering totals $18.0M, of which $18.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-04-23
- Form: D
- Accession: 0001461695-14-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $18.0M
- Amount sold: $18.0M
- Investors: 6
- Date of first sale: 2014-04-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-216080
Issuer
- Name: Nora Therapeutics, Inc.
- CIK: 0001461695
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 530 LYTTON AVENUE, 2ND FLOOR, PALO ALTO, CA, 94301
- Phone: 1-650-479-5331
Officers, directors & promoters (24)
| Name | Role | Location |
|---|
| Dennis J Fenton | Director | Palo Alto, CA |
| Bryant E Fong | Director | SAN FRANCISCO, CA |
| David E Schnell | Director | Palo Alto, CA |
| Chen E Yu | Director | Palo Alto, CA |
| CHEN YU | Director | PALO ALTO, CA |
| Donald J Hayden, Jr. | Director | Philadelphia, PA |
| David Schnell | Director | New York, NY |
| Joseph L Turner, Jr. | Director | Palo Alto, CA |
| Chen K Yu | Director | Palo Alto, CA |
| David K Schnell | Director | Palo Alto, CA |
| Dennis K Fenton | Director | Palo Alto, CA |
| Donald K Hayden, Jr. | Director | Palo Alto, CA |
| Anupam K Dalal | Director | Palo Alto, CA |
| Anupam J Dalal | Director | Palo Alto, CA |
| Martin J Vogelbaum | Director | Palo Alto, CA |
| Christopher B McClain | Executive Officer | Owing Mills, MD |
| Martin K Vogelbaum | Director | New York, NY |
| Jeffrey K Tong | Director | Palo Alto, CA |
| Jeffrey K Tong | Executive Officer | Palo Alto, CA |
| Darryl L Carter | Executive Officer | Owing Mills, MD |
| Alan K Colowick | Director | Palo Alto, CA |
| Alan K Colowick | Executive Officer | Palo Alto, CA |
| Julie McHugh | Director | Owing Mills, MD |
| Julie McHugh | Executive Officer | Owing Mills, MD |
Other filings by this issuer (5)
More